Lv2
176 积分 2025-10-15 加入
Unexpected aggressiveness in VHL-associated clear cell renal cell carcinoma: insights from two patients highlighting biological heterogeneity
3个月前
已关闭
The First Report of BRAF V600E Mutation in Paratesticular Mesothelioma
3个月前
已关闭
The role of circulating tumor DNA in precision adjuvant therapy for colorectal cancer: a scoping review
3个月前
已关闭
Expanding Bevacizumab-Erlotinib Therapy Through Fumarate Hydratase Deficiency Screening and Drug Target Pathway Analysis in Papillary Morphology Metastatic Renal Cell Carcinoma
4个月前
已关闭
Expanding Bevacizumab-Erlotinib Therapy Through Fumarate Hydratase Deficiency Screening and Drug Target Pathway Analysis in Papillary Morphology Metastatic Renal Cell Carcinoma
4个月前
已关闭
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
4个月前
已关闭
A randomized phase 2 trial of nivolumab, relatlimab plus ipilimumab vs. nivolumab plus ipilimumab in first-line advanced renal cell carcinoma
4个月前
已关闭
Preclinical and First-in-Human Study of Carbonic Anhydrase IX–Targeting Theranostic Pair, [ 68 Ga]Ga/[ 177 Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma
4个月前
已完结
Spatial Multiomic Analyses Reveal Carcinogenic Pathways in End-Stage Renal Disease
6个月前
已完结
Inflammation-Driven Field Cancerization in End-Stage Kidney Disease
6个月前
已完结
皖公网安备34019202002308
